Last checked at 6 Feb 2012 09:25
Phytopharm plc
Â
Annual Information Update
Phytopharm plc (the Company) announces that, in accordance with the requirements of Prospectus Rule 5.2 issued by the Financial Services Authority, and following publication of the Annual Report on 6 February 2012, the following information has been published or made available to the public between 8 February 2011 and 6 February 2012 inclusive, in compliance with laws and rules dealing with the regulation of securities, issuers of securities and securities markets.
1. Announcements made via the Regulatory Information Service ("RIS")
All the announcements listed below were published through a regulatory information service on the dates indicated. Copies can be obtained from the London Stock Exchange website, http://www.londonstockexchange.com or from the Company's website www.phytopharm.com
Date of publication | Title |
2 February 2012 | Appointment of Non-Executive Director |
27 January 2012 | Publication of 2011 annual report |
16 January 2012 | Research update |
11 January 2012 | Block listing cancellation |
3 January 2012 | Block listing interim review |
28 November 2011 | Director/PDMR shareholding |
28 November 2011 | Director/PDMR shareholding |
24 November 2011 | Final results |
8 November 2011 | Notice of results |
7 November 2011 | Block listing interim review |
4 October 2011 | Research update |
29 September 2011 | Research update |
16 August 2011 | Interim management statement |
28 July 2011 | Research update |
12 July 2011 | Block listing interim review |
5 July 2011 | Total voting rights |
17 June 2011 | Block listing interim review |
26 May 2011 | Half yearly report |
17 May 2011 | Notice of results |
5 May 2011 | Block listing interim review |
31 March 2011 | Results of AGM |
2 March 2011 | Holding(s) in Company |
15 February 2011 | Interim management statement |
7 February 2011 | Annual information update |
2. Documents published or sent to Shareholders or submitted to the FSA including those filed with the National Storage Mechanism:
Date of publication | Title |
27 January 2012 | Annual Report 2011 |
26 May 2011 | Interim Report 2011 |
30 March 2011 | AGM resolutions 2011 |
The 2011 Interim and 2011 Annual reports are available on the Company's website www.phytopharm.com
3. Documents filed at Companies House
The following documents were files at Companies House. Copies of these documents can be obtained from the Companies House website at www.companieshouse.gov.uk, or Companies House, Crown Way, Cardiff CF14 3UZ
Date of Publication | Title |
2 January 2012 | Form AP01 Appointment of Director |
27 January 2012 | Annual Report 2011 |
15 December 2011 | Form AR01 Annual return |
5 December 2011 | Form AD02 Single alternative inspection location |
6 June 2011 | Form AH01 Return of allotment of shares on 6 June 2011 |
31 March 2011 | AGM resolutions |
Copies of all documents referred to above are also available for inspection at the Company's registered office (Lakeview House, 2 Lakeview Court, Ermine Business Park, Huntingdon, Cambridgeshire PE29 6UA, United Kingdom) during normal business hours or by written request from the Company Secretary.
This annual information is required by, and is being made pursuant to, Article 10 of the Prospectus Directive as implemented by the UK Prospectus Rule 5.2 and not for any other purpose and neither the Company, nor any other person, takes any responsibility for, or makes any representation, express of implied, as to the accuracy or completeness of, the information which it contains. The information is not necessarily up to date as at the date of this annual information update and the Company does not undertake any obligation to update any such information in the future. Neither this annual information update, not referred to in it, constitutes, by virtue of this communication, an offer of securities addressed to any person and it should not be relied on by any person.
For further information, please contact:
Zoe McGowan, Company Secretary
Phytopharm plc Tel No: +44 (0)1480 437697
Further information about Phytopharm can be found on the Company's website www.phytopharm.com